{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0079" ],
      "Organ" : [ "uberon:UBERON:0006611" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Similarly, among patients with no diagnoses of impaired fasting glucose, impaired glucose tolerance, or abnormal glucose and no lab tests with blood glucose level> = 200 mg/dL in the pre-index period, we noted an increase in glucose intolerance based on diagnoses or lab tests during the post-index period from 16.0% in Q1 to 26.7% in Q4.",
  "reading_complete" : "2020-07-28T17:45:45Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:43:34Z",
  "trigger" : "level",
  "evidence" : [ "glucose level" ],
  "pmc_id" : "6858477",
  "score" : 0
}